These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20708791)

  • 1. A cell sorter with modified bamboo charcoal for the efficient selection of specific antibody-producing hybridomas.
    Lin CC; Ni MH; Chang YC; Yeh HL; Lin FH
    Biomaterials; 2010 Nov; 31(32):8445-53. PubMed ID: 20708791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of monoclonal antibodies against human epidermal growth factor receptor in Balb/c mice.
    Baradaran B; Hosseini AZ; Majidi J; Farajnia S; Barar J; Saraf ZH; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(1-2):11-6. PubMed ID: 19478394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of intracellular domain of epidermal growth factor receptor and generation of its monoclonal antibody.
    Lin Y; Liu Z; Jiang J; Jiang Z; Ji Y; Sun B
    Cell Mol Immunol; 2004 Apr; 1(2):137-41. PubMed ID: 16212901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody specific for T cell-derived human IgE binding factors.
    Kisaki T; Huff TF; Conrad DH; Yodoi J; Ishizaka K
    J Immunol; 1987 May; 138(10):3345-51. PubMed ID: 2437189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell pool.
    Bloor AG; Jou Y; Hoeplinger C; Gartner JE; Mayers GL; Bankert RB
    J Immunol; 1982 Mar; 128(3):1443-9. PubMed ID: 6173438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization.
    Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ
    Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional culture for monoclonal antibody production by hybridoma cells immobilized in macroporous gel particles.
    Nilsang S; Nehru V; Plieva FM; Nandakumar KS; Rakshit SK; Holmdahl R; Mattiasson B; Kumar A
    Biotechnol Prog; 2008; 24(5):1122-31. PubMed ID: 19194922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and identification of monoclonal antibodies against Penicillium marneffei].
    Qiu LW; Peng DX; Xu H; Jia J; Che XY; Yuen KY
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):38-9. PubMed ID: 12527512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and characterization of monoclonal antibody against DCXR].
    Ju YF; Yang JJ; Liu R; Gao Y; Liu XL; Gao JE; Sun QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):377-9. PubMed ID: 16643805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor.
    Staerz UD; Rammensee HG; Benedetto JD; Bevan MJ
    J Immunol; 1985 Jun; 134(6):3994-4000. PubMed ID: 2580901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of autoantibody reactivities in hybridoma collections derived from normal adult BALB/c mice.
    Freitas AA; Guilbert B; Holmberg D; Wennerström G; Coutinho A; Avrameas S
    Ann Inst Pasteur Immunol; 1986; 137D(1):33-45. PubMed ID: 3489435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K; Kipps TJ; Yang HM; Cheresh DA; Wargalla U; Sander DJ; Reisfeld RA
    Cancer Res; 1989 Jun; 49(11):2857-61. PubMed ID: 2720646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL; Schroff RW; Kipps TJ; Woodhouse CS; Abrams PG; Rager HC; Morgan AC; Foon KA
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of monoclonal antibody with anti-B specificity, to be used as reagent for blood classification].
    León G; Cruz C; Rojas L
    Invest Clin; 2004 Jun; 45(2):145-57. PubMed ID: 15211982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.